As such, ACLY is upregulated in a variety of tumors, and inhibition of ACLY genetically or pharmacologically significantly inhibits tumor growth in lung, prostate, or ovarian cancer xenograft mice.63 This evidence concerns the gene ACLY and ovarian carcinoma.